Brain MRI findings in aspartylglucosaminuria.

作者: Anna M. Tokola , Laura E. Åberg , Taina H. Autti

DOI: 10.1016/J.NEURAD.2015.03.003

关键词: Magnetic resonance imagingAspartylglucosaminuriaCerebellar atrophyMultiple sclerosisWhite matterFluid-attenuated inversion recoveryCavum veli interpositiRadiologyMedicinePathologyRare disease

摘要: Summary Background and purpose The aim of this study was to identify characteristic 3.0 T brain MRI findings in patients with aspartylglucosaminuria (AGU), a rare lysosomal storage disorder. Previous AGU patient material imaged at 1.0 1.5 T also re-evaluated. Materials methods Twenty-five examinations from 20 were included the study. Thirteen underwent prospective (5 male, 8 female, aged 9–45 years). Twelve nine (4 5 8–33 years) previously or Two both retrospective groups. Visual analysis T1- T2-weighted images performed by two radiologists. Results reported signal intensity changes visible all field strengths, but they more distinct than 1.5 T. These decrease thalami especially pulvinar nuclei, periventricular increase juxtacortical high foci. Poor differentiation between gray white matter found patients. Some degree cerebral and/or cerebellar atrophy mild ventricular dilatation nearly This disclosed various unspecific findings, including higher normal incidence dilated perivascular spaces, arachnoid cysts, pineal cysts mildly cavum veli interpositi. Conclusion revealed particular AGU, which can raise suspicion disease clinical practice.

参考文章(30)
Marja Hietala, Kristiina Grön, Ann-Christine Syvänen, Leena Peltonen, Perttì Aula, Prospects of carrier screening of aspartylglucosaminuria in Finland. European Journal of Human Genetics. ,vol. 1, pp. 296- 300 ,(1993) , 10.1159/000472427
Luigi Zecca, Moussa B. H. Youdim, Peter Riederer, James R. Connor, Robert R. Crichton, Iron, brain ageing and neurodegenerative disorders Nature Reviews Neuroscience. ,vol. 5, pp. 863- 873 ,(2004) , 10.1038/NRN1537
Salli Virta, Juhani Rapola, Anu Jalanko, Minna Laine, Use of nonviral promoters in adenovirus‐mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse Journal of Gene Medicine. ,vol. 8, pp. 699- 706 ,(2006) , 10.1002/JGM.892
P Arvio, M Arvio, Progressive nature of aspartylglucosaminuria Acta Paediatrica. ,vol. 91, pp. 255- 257 ,(2007) , 10.1111/J.1651-2227.2002.TB01707.X
J. L. Dietemann, C. Beigelman, L. Rumbach, M. Vouge, T. Tajahmady, C. Faubert, M. Y. Jeung, A. Wackenheim, Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data. Neuroradiology. ,vol. 30, pp. 478- 480 ,(1988) , 10.1007/BF00339686
Luca Saba, Michele Anzidei, Eytan Raz, Jasjit Suri, Mario Piga, Roberto Grassi, Carlo Catalano, MR and CT of Brain's Cava Journal of Neuroimaging. ,vol. 23, pp. 326- 335 ,(2013) , 10.1111/JON.12004
M. Patlas, M. Y. Shapira, A. Nagler, R. Sheffer, J. M. Gomori, MRI of mannosidosis Neuroradiology. ,vol. 43, pp. 941- 943 ,(2001) , 10.1007/S002340100607
Andrew J. Walsh, Gregg Blevins, R. Marc Lebel, Peter Seres, Derek J. Emery, Alan H. Wilman, Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. Radiology. ,vol. 270, pp. 186- 196 ,(2013) , 10.1148/RADIOL.13130474
Taina Autti, Raimo Joensuu, Laura Åberg, Decreased T2 signal in the thalami may be a sign of lysosomal storage disease Neuroradiology. ,vol. 49, pp. 571- 578 ,(2007) , 10.1007/S00234-007-0220-6
Elina Ikonen, Leena Peltonen, Mutations causing aspartylglucosaminuria (AGU): A lysosomal accumulation disease Human Mutation. ,vol. 1, pp. 361- 365 ,(1992) , 10.1002/HUMU.1380010503